In the January issue of the‘s Innov8 monthly newsletter, focusing on antibody and related topics, Rapid Novor Inc is featured alongside other renowned service providers. interviewed our co-founder and CEO, Mingjie Xie, and discussed on the importance of the antibody field in general, as well as new opportunities our REmAb™ antibody protein sequencing technologies can offer to scientists worldwide.

Now with REmAb™, we can sequence any given antibody proteins routinely. Book a meeting with our scientist and discuss in detail.